Alpha-2 macroglobulin is genetically associated with Alzheimer disease

Nature Genetics

Volumn 19, Issue 4, 1998, Pages 357-360

  Blacker, Deborah ^a,c   Wilcox, Marsha A ^c   Laird, Nan M ^c   Rodes, Linda ^a,b   Horvath, Steven M ^c   Go, Rodney C P ^d   Perry, Rodney ^d   Watson Jr , Bracie ^d   Bassett, Susan S ^e   McInnis, Melvin G ^e   Albert, Marilyn S ^a   Hyman, Bradley T ^a   Tanzi, Rudolph E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Psychiatry   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN;

ALZHEIMER DISEASE; ARTICLE; GENE DELETION; GENETIC LINKAGE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL;

AGE OF ONSET; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHROMOSOMES, HUMAN, PAIR 12; FAMILY; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HUMANS; LINKAGE (GENETICS); LOD SCORE; LOGISTIC MODELS; RISK FACTORS;

EID: 17344362232     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/1243     Document Type: Article

References (33)

1. Blacker, D. & Tanzi, R.E. The genetics of Alzheimer's disease: current status and future prospects. Arch. Neurol. 55, 294-296 (1998).
2. Strittmatter, W.J. et al. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 1977-1981 (1993).
3. Blacker, D. et al. APOE-4 and age-at-onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology 48, 139-147 (1997).
4. Farrer, L.A. et al. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J.A.M.A. 278, 1349-1356 (1997).
5. Kang, D.E. et al. Genetic association of the low density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49, 56-61 (1997).
6. Kounnas, M. et al. LDL-receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82, 331-340 (1995).
7. Borth, W. Alpha-2-macroglobulin, a multi-functional binding protein with targeting characteristics. F.A.S.E.B. J. 6, 3345-3353 (1992).
8. Strickland, D.K. et al. Sequence identity between the alpha-2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265, 17401-17404 (1990).
9. Lopes, M.B., Bogaev, C.A., Gonias, S.L. & Vandenberg, S.R. Expression of alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells. F.E.B.S. Lett. 338, 301-305 (1993).
10. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37, 211-217 (1995).
11. Du, Y. et al. Alpha-2-macroglobulin as a beta-amyloid peptide-binding plasma protease. J. Neurochem. 63, 299-305 (1997).
12. Hughes, S.R. et al. Alpha-2-macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc. Natl Acad. Sci. USA 95, 3275-3280 (1998).
13. Du, Y. et al. Alpha-2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem. 70, 1182-1188 (1998).
14. Qiu, W.Q. et al. Degradation of amyloid beta protein by a serine proteinase alpha-2-macroglobulin complex. J. Biol. Chem. 271, 8443-8451 (1996).
15. Narita, M., Holtzman, D.M., Schwartz, A.L. & Bu, G. Alpha-2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69, 1904-1911 (1997).
16. Pericak-Vance, M.A. et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. J.A.M.A. 278, 1237-1241 (1997).
17. Matthijs, G. & Marynen, P. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nuceic Acids Res. 19, 5102 (1991).
18. Spielman, R.S. & Ewens, W.J. A sibship test for linkage in the presence of association: The Sib Transmission/Disequilibrium. Am. J. Hum. Genet. 62, 450-458 (1998).
19. Krauter, K. et al. A second-generation YACcontig map of human chromosome 12. Nature 377, 321-333 (1995).
20. Wu, W.S. et al. Genetic studies on chromosome 12 in late onset Alzheimer's disease. J.A.M.A. in press (1998).
21. Meyer, M.R. et al. APOE polymorphism predicts when-not whether-individuals are predisposed to develop Alzheimer's disease. Nature Genet. 19, 321-322 (1998).
22. Bullido, M.J. et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature Genet. 18, 69-71 (1998).
23. Lambert, J-C. et al. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum. Mol. Genet. 7, 533-540 (1998).
24. Lambert, J-C. et al. Distortion of allelic expression of apotipoprotein E in Alzheimer's disease. Hum. Mol. Genet 6, 2151-2154 (1997).
25. Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid betapeptide deposition. Nature Genet. 17, 263-264 (1997).
26. Zhang, Z. et al. Inhibition of alpha-2-macroglobulin/proteinase-mediated degradation of amyloid beta peptide by apolipoprotein E and atpha-1-antichymotrypsin. Int. J. Exp. Clin. Invest. 3, 156-161 (1996).
27. Hollenbach, E., Ackermann, S., Hyman, B.T. & Rebeck, G.W. Confirmation of an association between a polymorphism in exon 3 of LRP and Alzheimer's disease. Neurology, in press.
28. Blacker, D. et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. Arch. Neurol. 51, 1198-1204 (1994).
29. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944 (1984).
30. Farrer, L.A. et al. Transmission and age-at-onset patterns in familial Alzheimer's disease: evidence for heterogeneity. Neurologyt 40, 395-403 (1990).
31. Corder, E.H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7, 180-184 (1994).
32. Terwilliger, J.D. & Ott, J. Handbook of Human Genetic Linkage. (Johns Hopkins University Press, Baltimore. 1994).
33. Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. & Lander, E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58, 1347-1363 (1996).